Побочные эффекты лекарственных средств: литература
Bernstein I. L., Gruchalla R. S., Lee R. E. et al. (eds.) Disease management of drug hypersensitivity: A practice parameter. Ann Allergy Asthma Immunol 1999; 83: 678-9.
Carroll M. C., Yueng-Yue K. A., Esterly N. B. et al. Drug-induced hypersensitiviiy syndrome in pediatric patients. Pediatrics 2001; 108: 485-92.
Gruchalla R. Understanding drug allergies. J Allergy Clin Immunol 2000; 105: S637-44.
Kelkar P. S., Li J. T. Cephalosporin allergy. N Engl J Med 2001; 345: 804-9.
Pumphrey R. S., Davis S. Under-reporting of antibiotic anaphylaxis may put patients at risk. Lancet 1999; 353: 1157-8.
Reilly T. P., Lash L. H.t Doll M. A. et al. A role for bioactivation and covalent binding within epidermal keratinoc- ytes in sulfonamide-induced cutaneous drug reactions. J Invest Dermatol 2000; 114:1164-73.
Viard I., Wehrli P., Bullani R. et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998; 282: 490-3.
Yawalkar N.. Egli F.y Hari Y. et al. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin Exp Allergy 2000; 30: 847-55.
Yawalkar N.j Shrikhande M, Hari Y. et al. Evidence for a role for IL-5 and eouxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. J Allergy Clin Immunol 2000; 106: 1171-6.
Смотрите также:
